MoneyWorks4Me

Lupin - Quaterly Results

09 May 2023 Evaluate
A slight decline in the revenue of Rs. 28362.70 millions was seen for the March 2023 quarter as against Rs. 28553.90 millions during year-ago period.The Total Profit for the quarter ended March 2023 of Rs. 1190.10 millions grew from Rs.-358.90 millionsA decline of 3174.80 millions was observed in the OP in the quarter ended March 2023 from 5171.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 28362.70 28553.90 -0.67 112588.30 117716.70 -4.36 112588.30 117716.70 -4.36
Other Income 553.00 161.50 242.41 912.60 1504.20 -39.33 912.60 1504.20 -39.33
PBIDT 3174.80 5171.50 -38.61 11739.20 4261.30 175.48 11739.20 4261.30 175.48
Interest 294.40 245.80 19.77 984.40 734.70 33.99 984.40 734.70 33.99
PBDT 2880.40 4925.70 -41.52 10754.80 3526.60 204.96 10754.80 3526.60 204.96
Depreciation 1462.00 1310.20 11.59 5483.40 5141.90 6.64 5483.40 5141.90 6.64
PBT 1418.40 3615.50 -60.77 5271.40 -1615.30 -426.34 5271.40 -1615.30 -426.34
TAX 228.30 3974.40 -94.26 1019.30 271.70 275.16 1019.30 271.70 275.16
Deferred Tax -25.90 3419.40 -100.76 60.40 -306.30 -119.72 60.40 -306.30 -119.72
PAT 1190.10 -358.90 -431.60 4252.10 -1887.00 -325.34 4252.10 -1887.00 -325.34
Equity 910.00 909.00 0.11 910.00 909.00 0.11 910.00 909.00 0.11
PBIDTM(%) 11.19 18.11 -38.20 10.43 3.62 188.03 10.43 3.62 188.03
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..